Papers: 10.3390/ijms21113805

https://doi.org/10.3390/ijms21113805

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

Cited by: 16
Author(s): Michele Bartoletti, Giacomo Pelizzari, Lorenzo Gerratana, L. Bortot, Davide Lombardi, Milena S. Nicoloso, Simona Scalone, Giorgio Giorda, Gustavo Baldassarre, Roberto Sorio, Fabio Puglisi
Published: about 5 years ago

Software Mentions 1